The Malaysian Journal of Analytical Sciences Vol 16 No 3 (2012): 213 – 219

 

 

 

DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR THE DETERMINATION OF LACIDIPINE IN PURE FORM AND IN PHARMACEUTICAL DOSAGE FORM

 

(Perkembangan dan Validasi Satu Kaedah KCPT Bagi Penentuan Lacidipine Tulen

dan Dalam Dos Farmaseutikal)

 

Mannur Vinodh*, Mastiholimath Vinayak, Kharya Rahul, Patware Pankaj

 

Department of Quality Assurance,

KLE University’s College of Pharmacy, Belgaum- 590 010, Karnataka, India

 

*Corresponding author: vinodhmannur@yahoo.com

 

 

Abstract

A simple and reliable high-performance liquid chromatography (HPLC) method was developed and validated for Lacidipine in pure form and pharmaceutical dosage form. The method was developed on Xbridge C-18 column (150 mm x 4.6 mm, 5 μm) with a mobile phase gradient system of ammonium acetate and acetonitrile. The effluent was monitored by PDA detector at 240 nm. Calibration curve was linear over the concentration range of 50 – 250 μg/ml. For Intra–day and inter–day precision % RSD values were found to be 0.83% and 0.41% respectively. Recovery of Lacidipine was found to be in the range of 99.78-101.76%. The limits of detection (LOD) and quantification (LOQ) were 1.0 and 7.3 μg/ml respectively. The developed RP-HPLC method was successfully applied for the quantitative determination of lacidipine in pharmaceutical dosage.

 

Keywords: Lacidipine, HPLC, Pharmaceutical dosage form, Validation

 

References

1.       British National Formulary; 58th Edition (September 2009) British Medical Association and Royal Pharmaceutical Society of Great Britain, London (http://bnf.org/bnf/bnf/current/).

2.       Martindale. (1996). The Extra Pharmacopeia, Royal Pharmaceutical Society, London. 31st ed., 898.

3.       Tripathi, K. D. (2008). Essentials of medical pharmacology jaypee brothers medical Publishers, 6th ed., 531-532.

4.       Baranda, A.B., Berasaluce, O., Jimenez, R.M., Alonso, R.M. (2005). LC-DAD Determination of calcium channel Blockersby Using an Experimental Design Approach. Chromatographia, 61(9-10) : 447-453.

5.       Kharat, V.R., Verma, K.K., Dhake, J.D. (2002).  Determination of Lacidipine from urine by HPTLC using off-line SPE. J Pharm Biomed Anal, 28(3-4) : 789-793.

6.        Marco Garzotti. (2003). Lacidipine, a potential peroxynitrite scavenger investigation of activity by liquid chromatography and mass spectrometry. Rapid Commun Mass Spectrum, 17(4) : 272-278.

7.       Filippis, P.De., Bovina, E. E., Fiori, J., Cavrini, V. (2002).  Photo degradation studies on Lacidipine in solution: basic experiments with a cis–trans reversible photoequilibrium under UV-A radiation exposure. J Pharm Biomed Anal 27(1-5) : 803-812.

8.       Ramesh, G., Vamshi Vishnu, Y., Chinna Reddy, P., Shravan Kumar, Y., Madhusudan Rao, Y. (2009). Development of High performance liquid chromatography method for Lacidipine in rabbit serum. Anal Chim Acta, 632(2) : 278-283.

9.       Rashmin. (2008). An introduction to analytical method development for pharmaceutical formulations. 6(4) : 102-115.

10.    Yamsani, M., Gannu, R., Yamsani, V.,  Reddy, P., and Yamsani, S. Available online 17   November (2008). Developed high performance liquid chromatographic (HPLC) method for quantification of Lacidipine in rabbit serum: Application to pharmacokinetic study.          

11.    Channabasavaraj, K.P., Nagaraju P.T., Shantha Kumar P.T., Srinivas Reddy P. November – December (2010).  Reverse phase HPLC method for determination of lacidipine in pharmaceutical preparations. Volume 5, Issue 2, Article-021.

12.    Braggio, S., Sartori, S., Angeri, F., Pellegatti, M. (1995). Automation and validation of the high-performance liquid chromatographic-radioimmunoassay method for the Determination of lacidipine in plasma. J of Chromatography B, 669 :  383-389.B

13.    Tang, J., Zhao, R., Cheng, G., Wenxing, P. (2008). Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of lacidipine in human plasma and its application in a pharmacokinetic study. J of Pharm and Biomed Ana, 47:  923–928.

 

 

Previous                    Content                    Next